SynGen Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1M
SynGen General Information
Description
Developer of instrument systems designed to harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood and cell culture. The company develops regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.
Contact Information
Website
www.syngeninc.comCorporate Office
- 6017 Snell Avenue Genprice
- San Jose, CA 95123
- United States
Corporate Office
- 6017 Snell Avenue Genprice
- San Jose, CA 95123
- United States
SynGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 07-Jul-2017 | $1M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 26-Jun-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 10-May-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 06-Oct-2014 | Completed | Startup | |||
| 3. Debt - General | 27-Feb-2014 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 09-Jul-2013 | $1M | $6M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Apr-2012 | $5M | $5M | Completed | Startup |
SynGen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
SynGen Comparisons
Industry
Financing
Details
SynGen Competitors (16)
One of SynGen’s 16 competitors is Synthecon, a Formerly Accelerator/Incubator backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synthecon | Formerly Accelerator/Incubator backed | Houston, TX | ||||
| StemExpress | Corporation | Folsom, CA | ||||
| StressMarq Biosciences | Corporation | Victoria, Canada | ||||
| OriGen Biomedical | Corporation | Austin, TX | ||||
| STEMCELL Technologies | Private Debt Financed | Vancouver, Canada |
SynGen Patents
SynGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017117349-A2 | Cell separation devices, systems, and methods | Inactive | 29-Dec-2015 | ||
| WO-2017117349-A3 | Cell separation devices, systems, and methods | Inactive | 29-Dec-2015 | ||
| JP-2018525193-A | Method for preparing an osteogenic bone graft | Active | 31-Jul-2015 | ||
| WO-2017023542-A1 | Method of preparing an osteogenic bone graft | Inactive | 31-Jul-2015 | ||
| WO-2016183018-A1 | Cryogenic storage bag | Inactive | 12-May-2015 | A61J1/10 |
SynGen Signals
SynGen Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bay City Capital | Venture Capital | Minority |
SynGen FAQs
-
When was SynGen founded?
SynGen was founded in 2009.
-
Where is SynGen headquartered?
SynGen is headquartered in San Jose, CA.
-
What is the size of SynGen?
SynGen has 24 total employees.
-
What industry is SynGen in?
SynGen’s primary industry is Other Devices and Supplies.
-
Is SynGen a private or public company?
SynGen is a Private company.
-
What is the current valuation of SynGen?
The current valuation of SynGen is .
-
What is SynGen’s current revenue?
The current revenue for SynGen is .
-
How much funding has SynGen raised over time?
SynGen has raised $20.7M.
-
Who are SynGen’s investors?
Bay City Capital has invested in SynGen.
-
Who are SynGen’s competitors?
Synthecon, StemExpress, StressMarq Biosciences, OriGen Biomedical, and STEMCELL Technologies are some of the 16 competitors of SynGen.
-
When was SynGen acquired?
SynGen was acquired on 07-Jul-2017.
-
Who acquired SynGen?
SynGen was acquired by ThermoGenesis Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process